Charles Horton Sr. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 301 Spring Garden Road, Winslow, NJ 08095 Phone: 609-561-0269 Fax: 609-561-7604 |
Pamela Dobbs, LCADC, CCS, CCGC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 301 Spring Garden Road, Winslow, NJ 08095 Phone: 609-561-4990 |
News Archive
International leaders are failing to adequately respond to what is the worst Ebola epidemic in history, announced Doctors Without Borders/Médecins Sans Frontières (MSF) at a United Nations briefing held on Tuesday.
Medtronic, Inc. today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain Stimulation (DBS) Therapy in Europe as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy. DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus, which is part of a circuit involved in seizures.
Sanofi announced today data that demonstrates that initiating Lantus® (insulin glargine [rDNA origin] injection) in type 2 diabetes patients leads to better glycemic control and comparable and modest weight gain versus a comparator group consisting of other insulins, oral antidiabetics and dietary changes.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
› Verified 5 days ago